• Produktbild: Clinical Drug Trials and Tribulations, Revised and Expanded
  • Produktbild: Clinical Drug Trials and Tribulations, Revised and Expanded

Clinical Drug Trials and Tribulations, Revised and Expanded

Fr. 332.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

26.03.2002

Verlag

Taylor and Francis

Seitenzahl

484

Maße (L/B/H)

24/16.1/3 cm

Gewicht

816 g

Auflage

2. Auflage

Sprache

Englisch

ISBN

978-0-8247-0314-1

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

26.03.2002

Verlag

Taylor and Francis

Seitenzahl

484

Maße (L/B/H)

24/16.1/3 cm

Gewicht

816 g

Auflage

2. Auflage

Sprache

Englisch

ISBN

978-0-8247-0314-1

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Clinical Drug Trials and Tribulations, Revised and Expanded
  • Produktbild: Clinical Drug Trials and Tribulations, Revised and Expanded
  • Current Challenges and Future Directions of Drug Development
    Allen Cato, Lynda Sutton, and Allen Cato III
    Preclinical Drug Discovery and Development
    David S. Duch and Robert M. Ferris
    The IND Process for New Drug Products
    David M. Cocchetto
    Performance and Interpretation of Laboratory Tests
    W. Leigh Thompson, Rocco L. Brunelle, and Michael G. Wilson
    Issues in Endpoint Selection
    Karen D. Weiss and Jay Philip Siegel
    Dix, Cent, Mille: Proof of Principle with $10 Million, 100 Patients, and 1000 Days
    W. Leigh Thompson
    Clinical Drug Trials in Pediatrics: Dilemmas of Clinical Drug Trials in Pediatric Populations
    Allen Cato and Myron B. Peterson
    Electronic Capture of Clinical Trial Information
    Daniel C. Cato and David B. Thomas
    Providing Patient Access to Promising Investigational Drugs
    Peggy J. Berry and Allen Cato
    Issues in the Review of Clinical Drug Trials by IRBs
    Dale H. Cowan
    Personal Care and Randomized Clinical Trials: Understanding the Ethical Conflicts
    Paul J. Reitemeier
    Informed Consent in Clinical Trials: Emerging Issues
    Cheryl K. Fiedler and H. Russell Searight
    Orphan Drug Development: David and Goliath
    Allen Cato, Susan L. Watts, Lynda Sutton, and Marlene E. Haffner
    Single-Event Adverse Drug Reactions: Tribulations in Ascribing Causality
    Nelson S. Irey
    How to Deal with a Sudden, Unexpected Death in Clinical Studies
    Allen Cato and Lynda Sutton
    Clinical Trial Material-The Fuel for Clinical Research
    David F. Bernstein
    The Role of Pharmacokinetics in Drug Development
    Allen Cato III and Richard Granneman
    Building an NDA/BLA
    Diana E. Fordyce and Angela Cahill
    International Planning of Drug Clinical Trials
    David L. Horwitz
    Uncertainty in Drug Development: Approval Success Rates for New Drugs
    Joseph A. DiMasi
    Contract Clinical Research: Value to In-House Drug Development
    F. Richard Nichol
    Package Inserts as Viewed by the Busy Private Practitioner
    Jean M. Findlay
    New Directions in Pharmaceutical Promotion: Regulatory Concerns and Contrivances
    Louis A. Morris and Peter H. Rheinstein
    The Campus Researcher and Industry: Issues of Intellectual Property and Technology Transfer
    Todd S. Keiller
    Anatomy of Drug Withdrawals in the United States
    Marion J. Finkel
    Appendices: Routine Clinical Analyte Test Results
    Index